UiPath Inc. (PATH) — Fair Value Analysis

Base-case fair value (P50): $14.17 · Current price: $10.81 · Verdict: Undervalued

The Verdict on PATH

Our Monte Carlo simulations indicate that UIPATH INC CLASS A (PATH) is currently Fairly Valued. At a $10.81, PATH trades below our median fair value (P50) of $14.17, implying a significant +31.0% potential. This robust analysis, derived from thousands of forward-looking scenarios, suggests that investors looking at the current market price shouldn't consider PATH overvalued based on this quantitative framework. The gap between $10.81 and $14.17 signals that, while not a screaming bargain, there's clear room for appreciation towards its intrinsic valuation.

How PATH stacks up against peers

Despite the sector being noted as n/a, our quality tier assessment for PATH is "average," reflecting its operational and financial health. This "average" quality doesn't detract from the +31.0% identified by our Monte Carlo analysis. Even with an average competitive standing, the simulations find the stock trading at $10.81 offers a favorable risk-reward profile when benchmarked against its simulated intrinsic value of $14.17. This suggests that fundamental drivers, despite a middling quality assessment, still point towards a discounted valuation at the current level.

What this means for investors

For investors, the Fairly Valued verdict on PATH, coupled with an implied +31.0% to its $14.17 fair value, presents an interesting proposition. Trading at $10.81, the stock appears to have a measurable runway for growth. While our quality assessment places PATH as "average," the Monte Carlo model effectively quantifies this potential upside, suggesting current levels are not indicative of an overvalued asset. FairCurve users can explore the full distribution of bear and bull case scenarios to understand the probabilistic outcomes. Sign up for FairCurve today to see the full bear/bull distribution and track PATH's fair value as new fundamentals are released.